Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

The Pfizer vaccine is the first to receive FDA approval, while the Moderna and Johnson & Johnson vaccines are available under an emergency use authorization. For children ages 12 to 15, Pfizer's ...

Pfizer, BioNTech and Moderna are experiencing a post-vaccine hangover on Wall Street this year. All three stocks surged spectacularly in 2021, thanks largely to their Covid-19 vaccines’ success ...

What's happening Updated COVID boosters from Pfizer and Moderna are available to everyone 6 months and older. Some adults can get Novavax for a booster instead. Why it matters As the virus mutates ...

Pfizer(PFE -0.46%) and Moderna (MRNA -1.74%) have been in agreement on a lot since the beginning of the pandemic. They both recognized the importance of eventually launching combined vaccines ...

Moderna said Friday that Pfizer and Germany-based BioNTech’s COVID-19 vaccine, Comirnaty, infringes on patents Moderna filed several years ago protecting the technology behind its preventive ...